Volume 3 - Issue 4

---

Production of antibodies against HER2 and HER3 receptors in breast cancer treatment and the superior effect of the synchronous blockade of these receptors

WCRJ 2016; 3 (4): e810
DOI: 10.32113/wcrj_201612_810

The transition from virtual reality to real virtuality: advanced imaging and simulation in general surgery

WCRJ 2016; 3 (4): e807
DOI: 10.32113/wcrj_201612_807

An epidemiological study of patients with breast cancer in Northern Iran, between 2006 and 2015

WCRJ 2016; 3 (4): e803
DOI: 10.32113/wcrj_201612_803

Costs and quality of genomics tests in the oncology field

WCRJ 2016; 3 (4): e801
DOI: 10.32113/wcrj_201612_801

A cost-effectiveness method for detection of ABL mutations in patients who developed Imatinib resistance

WCRJ 2016; 3 (4): e799
DOI: 10.32113/wcrj_201612_799

Recent evolutions on cancer clinical aspects and therapeutics approach. Naples (Italy) 11-12 July 2016

WCRJ 2016; 3 (4): e790
DOI: 10.32113/wcrj_201612_790

Nutraceutical agents with hepatoprotective effects in cancer patients

WCRJ 2016; 3 (4): e788
DOI: 10.32113/wcrj_201612_788

Commentary – Beliefs and preferred communication channels toward patients with cancer in Jordan

WCRJ 2016; 3 (4): e786
DOI: 10.32113/wcrj_201612_786